NCT06383442Completed
HIIT on Overweight Middle-aged Adults
Effects of Different Types of High Intensity Intermittent Training Combined With Resveratrol Supplementation on Oxidative Stress, Metabolic Adaption and Fat Loss in Aged and Overweight Groups
Source: ClinicalTrials.gov · Last updated 25 Apr 2024
Brief summary (registry, in English)
36 middle-aged with overweight adults were divided into three groups: 1. L-HIIT group: the long-interval HIIT group (4 × 4 min Exercise/4 min Rest), 2. M-HIIT group: the medium-interval HIIT group (8 × 2 min Exercise/2 min Rest), 3. Control group: no exercise intervention. All groups carried out the training stage for 8 weeks (three sessions per week) and the detraining stage for 4 weeks in order to investigate the effects induced by different HIIT interventions on inflammation, metabolic adaptation, anti-fatigue and exercise performance, and fat loss.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 36 (actual)
- First submitted
- 15 Apr 2024
- Start date
- 25 May 2021
- Primary completion date
- 31 Jul 2023
- Lead sponsor
- Taipei Medical University
- Diseases
- Obesity
- NCT number
- NCT06383442
What you commit to
- Study type: Interventional
- Participants enrolled: 36
- From 25 May 2021 to the primary completion date, 31 Jul 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- If there are any of the following circumstances, they are not allowed to participate in this research and are included in the listing conditions of this case:
- Have smoking and drinking habits.
- People who have stroke, type 1 and type 2 diabetes, neuromuscular disease, so that they cannot participate in physical activities.
- Chronic obstructive lung disease, asthma, interstitial lung disease or alveolar cyst fibrosis.
- Metabolic diseases include thyroid disease, kidney disease (kidney, bladder stones) or liver disease.
- Those with arrhythmia, a rhythm regulator, severe cardiovascular disease, peripheral vascular disease or cerebrovascular disease.
- People with epilepsy and rheumatoid arthritis.
- Those who have implanted artificial joints in the past six months and have had recent surgery.
- Migraine, acute thrombosis and hernia.
- Those who have engaged in strenuous exercise or have muscle aches within 24 hours before the experiment.
- People who feel unwell due to other reasons during the experiment.
- People with severe food allergies.
- Have hospitalization records within three months.
- People with cognitive impairment.
- Take any drugs that affect the function of the nervous system.
Who the study is looking for
- Recruit people who are overweight or obese (BMI between 24-35) who are 20-65 years old and have no exercise habits in a sitting lifestyle.
Age in the registry: 20 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Taipei Medical University Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.